Please wait while the formulary information is being retrieved.
VALPROIC ACID (VALPROATE SODIUM)
- Complex-partial epilepsy
- Epilepsy
- Absence epilepsy
- Valproic Acid (as Sodium Salt) Syrup
- Valproic Acid (as Sodium Salt) Oral Solution
- Valproic Acid (as Sodium Salt) Oral Soln
- By Indication
(as sodium salt) 250 mg/5 mL (5 mL) oral solution
- Dosage information is not available
(as sodium salt) 250 mg/5 mL oral solution
- 5 milliliters (250 mg) by oral route every 8 hours
(as sodium salt) 500 mg/10 mL (10 mL) oral solution
- Dosage information is not available
(as sodium salt) 250 mg/5 mL (5 mL) oral solution
- Dosage information is not available
(as sodium salt) 250 mg/5 mL oral solution
- 5 milliliters (250 mg) by oral route every 8 hours
(as sodium salt) 500 mg/10 mL (10 mL) oral solution
- Dosage information is not available
250 mg/5 mL (5 mL) oral solution
- Dosage information is not available
250 mg/5 mL oral solution
- 5 milliliters (250 mg) by oral route every 8 hours
500 mg/10 mL (10 mL) oral solution
- Dosage information is not available
Absence epilepsy
- 20 milliliters (1,000 mg) by oral route every 8 hours
- 5 milliliters (250 mg) by oral route every 8 hours
- 7.5 milliliters (375 mg) by oral route every 8 hours
- 10 milliliters (500 mg) by oral route every 8 hours
- 15 milliliters (750 mg) by oral route every 8 hours
Bipolar disorder
- 5 milliliters (250 mg) by oral route every 8 hours
Complex-partial epilepsy
- 5 milliliters (250 mg) by oral route every 8 hours
Epilepsy
- 5 milliliters (250 mg) by oral route every 8 hours
Myoclonic epilepsy
- 5 milliliters (250 mg) by oral route every 8 hours
Simple-partial epilepsy
- 5 milliliters (250 mg) by oral route every 8 hours
Tonic-clonic epilepsy
- 5 milliliters (250 mg) by oral route every 8 hours
- None
Contraindicated
- Doribax
- doripenem
- ertapenem
- imipenem-cilastatin
- Invanz
- Lamictal
- Lamictal Odt
- Lamictal Odt Starter (blue)
- Lamictal Odt Starter (green)
- Lamictal Odt Starter (orange)
- Lamictal Starter (blue) Kit
- Lamictal Starter (green) Kit
- Lamictal Starter (orange) Kit
- Lamictal Xr
- Lamictal Xr Starter (blue)
- Lamictal Xr Starter (green)
- Lamictal Xr Starter (orange)
- lamotrigine
- meropenem
- Merrem
- Primaxin Iv
- vorinostat
- Zolinza
Severe
Moderate
- acetaminophen-mag sal-pamabrom
- Added Strength Headache Relief
- Added Strength Pain Reliever
- Adult Low Dose Aspirin
- Aggrenox
- Alka-seltzer
- Alka-seltzer Extra Strength
- Alka-seltzer Original
- Alka-seltzer Plus C/c(pe,dm)
- Alka-seltzer Plus Cold (pe)
- Alka-seltzer Plus Day-night
- Alka-seltzer Plus Night
- Alka-seltzer Pm
- amitriptyline
- amitriptyline-chlordiazepoxide
- Anacin
- Anacin Maximum Strength
- Anafranil
- Analgesic
- Antacid & Pain Relief
- Arthri-flex
- ASA-acetaminophen-caff-buffers
- ASA-acetaminophen-salicyl-caff
- Ascomp With Codeine
- Aspir-81
- Aspir-low
- Aspir-trin
- aspirin
- Aspirin Childrens
- Aspirin Low Dose
- Aspirin Low-strength
- aspirin, buffered
- aspirin-acetaminophen-caffeine
- aspirin-caffeine
- aspirin-calcium carbonate
- aspirin-diphenhydramine
- aspirin-diphenhydramine citrat
- aspirin-sod bicarb-citric acid
- Ativan
- Back & Body Pain Reliever
- Back Pain-off
- Backache Relief
- Backache Relief Extra Strength
- Banzel
- Bayer Advanced
- Bayer Aspirin
- Bayer Aspirin (with Caffeine)
- Bayer Back & Body
- Bayer Chewable Aspirin
- Bayer Childrens Aspirin
- Bayer Plus Extra Strength
- Bayer Pm
- Bc
- Bc Arthritis
- Bismatrol
- Bismuth
- Bismuth Maximum Strength
- bismuth subsalicylate
- Buffered Aspirin
- Bufferin
- Butalbital Compound W/codeine
- Butalbital Compound-codeine
- butalbital-aspirin-caffeine
- carbamazepine
- Carbatrol
- carisoprodol-ASA-codeine
- carisoprodol-aspirin
- Child Aspirin
- Children's Aspirin
- chlorphen-phenyleph-DM-aspirin
- chlorphenir-phenylephrn-aspirn
- choline & magnesium salicylate
- clomipramine
- codeine-butalbital-ASA-caff
- Cold Relief
- Cold Relief Plus
- Coumadin
- Cystex (methenamine & Sod Sal)
- Diarrhea Relief (bismuth Subs)
- dihydrocodeine-aspirin-caff
- Diotame
- Diotame Instydose
- Dipentum
- dipyridamole-aspirin
- doxylamine-phenylep-DM-aspirin
- E.c. Prin
- Ecotrin
- Ecotrin Low Strength
- Efferves Pain Relief Antacid
- Effervescent Antacid
- Effervescent Pain Relief
- Effervescent Pain Reliever
- Endodan
- Enteric Coated Aspirin
- Epitol
- Equetro
- Excedrin Extra Strength
- Excedrin Migraine
- Extra Strength Bayer
- felbamate
- Felbatol
- Fiorinal
- Fiorinal-codeine #3
- gluc-msm-coll2-hyal-antiarthr3
- glucos-msm-C-Mn-ginger-willow
- glucos-msm-C-Mn-herb#21
- glucos-msm-collagen-C-Mn-hrb21
- Glucosamine-msm Complex
- Goody's Extra Strength
- Goody's Migraine Relief
- Headache Formula
- Headache Formula Added Str
- Headache Relief
- Hyophen
- isoniazid-rifamp-pyrazinamide
- Jantoven
- K-pec Antidiarrheal (bism Sub)
- Kao-tin (bismuth Subsalicylat)
- Kaopectate (bismuth Subsalicy)
- Kaopectate Child(bis Ssalicyl)
- Kaopectate Ex Str (bismuth Ss)
- Kola-pectin Ds
- Levacet
- Lite Coat Aspirin
- Lo-dose Aspirin
- lorazepam
- Lorazepam Intensol
- magnesium salicylate
- Medi-bismuth
- Medi-seltzer
- methen-hyos-me blue-ba-salicyl
- methen-hyosc-m.blue-sal-naphos
- methenamine-sodium salicylate
- Mg salicylat-acetaminophen-caf
- Migraine Formula
- Migraine Pain Reliever
- Migraine Relief
- Msm Glucosamine Complex
- mth-me blue-sod phos-phsal-hyo
- nimodipine
- nortriptyline
- Nymalize
- olsalazine
- Orphenadrine Compound Forte
- Orphenadrine Compound-ds
- orphenadrine-ASA-caffeine
- oxycodone-aspirin
- Pain Relief
- Pain Relief Extra Strength
- Pain Reliever
- Pain Reliever Extra Strength
- Pain Reliever Plus
- Pain-off
- Pamelor
- Pamprin (with Mag Salicylate)
- Pamprin Max
- PE-DM-ASA/doxyla-PE-DM-ASA
- Peptic Relief
- Pepto-bismol
- Pepto-bismol Max St
- Pepto-bismol To-go
- Percodan
- perphenazine-amitriptyline
- phentermine-topiramate
- Phosphasal
- Pink Bismuth
- Pink Bismuth Maximum Strength
- Prosed/ds (atropine Free)
- Qsymia
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- Rifater
- rufinamide
- salsalate
- Soothe (bismuth Subsalicylate)
- Soothe Regular Strength
- St Joseph Aspirin
- St. Joseph Aspirin
- Stomach Relief
- Stomach Relief Max Strength
- Stomach Relief Original
- Super Pain Relief
- Synalgos-dc
- Tegretol
- Tegretol Xr
- Topamax
- Topiragen
- topiramate
- Tri-buffered Aspirin
- Trokendi Xr
- Ur N-c
- Urelle
- Uretron D-s
- Uribel
- Urimar-t
- Urin Ds
- Ustell
- Uta
- Vanquish
- warfarin
- Women's Aspirin With Calcium
- Acute pancreatitis
- Disease of liver
- Hereditary syndromes due to POLG gene mutations
- Ornithine carbamoyltransferase deficiency
- Urea cycle disorder
Contraindicated
- Hyperammonemia
- Organic mental disorder
- Porphyria
- Pregnancy
- Suicidal ideation
Severe
Moderate
- Depression
- Hypoalbuminemia
- Thrombocytopenic disorder
VALPROIC ACID (VALPROATE SODIUM)
- Complex-partial epilepsy
- Epilepsy
- Absence epilepsy
- Accidental injury
- Dyspnea
- Nystagmus
- Peripheral edema
- Thrombocytopenic disorder
- Acute abdominal pain
- Alopecia
- Anorexia
- Ataxia
- Blurred vision
- Bronchitis
- Constipation
- Depression
- Diarrhea
- Diplopia
- Dizziness
- Drowsy
- Dyspepsia
- Ecchymosis
- Fever
- Flu-like symptoms
- General weakness
- Headache disorder
- Increased appetite
- Infection
- Insomnia
- Irregular menstrual periods
- Memory impairment
- Nausea
- Pharyngitis
- Rhinitis
- Tinnitus
- Tremor
- Vomiting
- Weight gain
- Weight loss
More Frequent
Severe
Less Severe
- Altered mental status
- Mood changes
- Back pain
- Gait abnormality
- Injection site sequelae
- Irritability
- Nervousness
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Abnormal spermatozoa morphology
- Acute hepatic failure
- Acute intermittent porphyria
- Acute pancreatitis
- Agranulocytosis
- Anaphylaxis
- Anemia
- Aplastic anemia
- Behavioral disorders
- Bloody vomit
- Bradycardia
- Cerebral pseudoatrophy
- Cutaneous vasculitis
- Cystitis
- DRESS syndrome
- Encephalopathy
- Eosinophilia
- Erythema multiforme
- Facial edema
- Fracture
- Hearing loss
- Hepatitis
- Hyperammonemia
- Hyperandrogenism
- Hypertension
- Hypothermia
- Jaundice
- Leukopenia
- Lymphadenopathy
- Lymphocytosis
- Macrocytosis
- Myocarditis
- Nephritis
- Neutropenic disorder
- Osteoporosis
- Pancytopenia
- Paradoxical convulsion
- Parkinsonism
- Platelet aggregation inhibition
- Polycystic ovarian syndrome
- SIADH syndrome
- Skin photosensitivity
- Stevens-johnson syndrome
- Suicidal ideation
- Tardive dyskinesia
- Toxic epidermal necrolysis
Less Severe
- Abnormal hair texture
- Abnormal vaginal bleeding
- Aggressive behavior
- Agitation
- Amblyopia
- Asthenozoospermia
- Azoospermia
- Bone pain
- Chest pain
- Conjunctivitis
- Cough
- Cramps in legs
- Disturbance of attention
- Dream disorder
- Dry skin
- Dysmenorrhea
- Dysuria
- Epistaxis
- Excitement
- Flatulence
- Galactorrhea not associated with childbirth
- Gynecomastia
- Hair discoloration
- Hirsutism
- Hostility
- Hyperreflexia
- Hypertonia
- Hypokinesia
- Increased urinary frequency
- Indifference
- Maculopapular rash
- Malaise
- Menstrual disorder
- Muscle weakness
- Nail disorders
- Oligospermia
- Osteopenia
- Palpitations
- Panic disorder
- Parotitis
- Personality disorders
- Petechiae
- Seborrhea
- Secondary amenorrhea
- Sinusitis
- Skin rash
- Stomatitis
- Symptoms of anxiety
- Tachycardia
- Urinary incontinence
- Urinary tract infection
- Vertigo
- Visual changes
- Xerostomia
Contraindicated
None
Severe Precaution
Valproic Acid(Valproate Sodium)
Risk of serious or fatal hepatotoxicity in age < 2 years, especially in children with congenital metabolic disorders, mental retardation, organic brain disease, and children taking multiple anticonvulsants. Contraindicated in patients suspected of having a mitochondrial disorder. Also reports of life-threatening pancreatitis. Use as single agent and monitor patients closely if used. Monitor liver enzymes and VPA levels.
- 1 Day – 2 Years
- Risk of serious or fatal hepatotoxicity in age < 2 years, especially in children with congenital metabolic disorders, mental retardation, organic brain disease, and children taking multiple anticonvulsants. Contraindicated in patients suspected of having a mitochondrial disorder. Also reports of life-threatening pancreatitis. Use as single agent and monitor patients closely if used. Monitor liver enzymes and VPA levels.
Management or Monitoring Precaution
Valproic Acid(Valproate Sodium)
Counsel post-menarche females on appropriate contraception. Risk of fatal hepatotoxicity, especially in younger children, with POLG gene mutations, or on multiple anticonvulsants. Monitor for liver impairment including non-specific symptoms (e.g., lethargy, facial edema, vomiting). Rare risk of pancreatitis, impaired mitochondrial metabolism associated with hypocarnitinemia. Psychiatric changes (e.g., aggression, agitation, disturbed attention, learning disorders) may be more prevalent.
Risk of fatal hepatotoxicity, especially in younger children, with POLG gene mutations, and on multiple anticonvulsants. Monitor closely for liver impairment including non-specific symptoms (e.g., lethargy, facial edema, vomiting). Rare risk of pancreatitis, impaired mitochondrial metabolism associated with hypocarnitinemia. Adverse psychiatric changes (e.g., aggression, agitation, disturbed attention, and learning disorders). Monitor liver enzymes, VPA levels behavior.
- 10 Years – 18 Years
- Counsel post-menarche females on appropriate contraception. Risk of fatal hepatotoxicity, especially in younger children, with POLG gene mutations, or on multiple anticonvulsants. Monitor for liver impairment including non-specific symptoms (e.g., lethargy, facial edema, vomiting). Rare risk of pancreatitis, impaired mitochondrial metabolism associated with hypocarnitinemia. Psychiatric changes (e.g., aggression, agitation, disturbed attention, learning disorders) may be more prevalent.
- Risk of fatal hepatotoxicity, especially in younger children, with POLG gene mutations, and on multiple anticonvulsants. Monitor closely for liver impairment including non-specific symptoms (e.g., lethargy, facial edema, vomiting). Rare risk of pancreatitis, impaired mitochondrial metabolism associated with hypocarnitinemia. Adverse psychiatric changes (e.g., aggression, agitation, disturbed attention, and learning disorders). Monitor liver enzymes, VPA levels behavior.
- 2 Years – 10 Years
- Counsel post-menarche females on appropriate contraception. Risk of fatal hepatotoxicity, especially in younger children, with POLG gene mutations, or on multiple anticonvulsants. Monitor for liver impairment including non-specific symptoms (e.g., lethargy, facial edema, vomiting). Rare risk of pancreatitis, impaired mitochondrial metabolism associated with hypocarnitinemia. Psychiatric changes (e.g., aggression, agitation, disturbed attention, learning disorders) may be more prevalent.
- Risk of fatal hepatotoxicity, especially in younger children, with POLG gene mutations, and on multiple anticonvulsants. Monitor closely for liver impairment including non-specific symptoms (e.g., lethargy, facial edema, vomiting). Rare risk of pancreatitis, impaired mitochondrial metabolism associated with hypocarnitinemia. Adverse psychiatric changes (e.g., aggression, agitation, disturbed attention, and learning disorders). Monitor liver enzymes, VPA levels behavior.
Valproic Acid(valproate Sodium)
- Severity Level:
D
- Additional Notes: Incr risk of neural tube defects and lower iq, consider maternal tx benefit
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Valproic Acid(valproate Sodium)
Limited data suggest minimal amnt excreted;Monitor infant for adverse effects
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest minimal amnt excreted;Monitor infant for adverse effects |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Valproic Acid
Hepatic-Elderly may have slower metabolism and protein binding which requires dosage reduction. Monitor closely. Neuro/Psych-Use caution in elderly with a history of recurrent falls. Drug may produce somnolence, ataxia, impaired psychomotor function, syncope, and additional falls. Monitor fluid and nutritional intake and avoid dehydration. Musculoskeletal-Postmarketing reports of fractures, decreased bone mineral density, osteopenia, osteoporosis.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | Y | N | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
No Known Risk
None
- Rarely, this medication has caused serious (sometimes fatal) liver problems, usually within the first 6 months of starting treatment. Laboratory tests should be performed before you start treatment and periodically during treatment, especially within the first 6 months, to monitor this side effect. The risk of serious liver problems is increased in children younger than 2 years, especially if they have an inherited metabolic disorder, severe seizure disorder with mental retardation, organic brain disease, or if they take more than one seizure medication.<br /><br />Talk with the doctor about the risks and benefits of using this medication in children younger than 2 years. Due to an increased risk for liver problems, people with certain inherited metabolic disorders (such as Alpers-Huttenlocher syndrome) should not use this medication. Children younger than 2 years who might have these disorders should not use this medication.<br /><br />Children older than 2 years who might have these disorders should be closely monitored during treatment with valproate sodium. Talk to your doctor for details. This medication has rarely caused severe (sometimes fatal) disease of the pancreas (pancreatitis).<br /><br />This may occur at any time during treatment and can quickly worsen. Tell your doctor right away if you develop symptoms of liver problems or pancreatitis such as unusual tiredness, weakness, swelling of the face, stomach/abdominal pain, loss of appetite, dark urine, yellowing eyes/skin, or persistent nausea/vomiting. Taking this medication during pregnancy can cause birth defects and may lower your child's IQ.<br /><br />Women of childbearing age should discuss the risks and benefits of this medication, other treatment options, and use of reliable forms of birth control with their doctor. If you are planning pregnancy, become pregnant, or think you may be pregnant, immediately talk to your doctor. If you are taking valproate sodium only to prevent migraine headaches, this medication must not be used during pregnancy.<br /><br />If you are taking valproate sodium to treat seizures or mental/mood problems (such as bipolar disorder), do not stop taking this medication unless directed by your doctor. Untreated seizures and mental/mood problems (such as bipolar disorder) are serious conditions that can harm both a pregnant woman and her unborn baby.
| Absence epilepsy | |
| G40.A | Absence epileptic syndrome |
| G40.A0 | Absence epileptic syndrome, not intractable |
| G40.A09 | Absence epileptic syndrome, not intractable, without status epilepticus |
| G40.A1 | Absence epileptic syndrome, intractable |
| G40.A19 | Absence epileptic syndrome, intractable, without status epilepticus |
| Complex-partial epilepsy | |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| Epilepsy | |
| E88.42 | MERRF syndrome |
| G40 | Epilepsy and recurrent seizures |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.001 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.011 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.101 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.111 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.201 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.211 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| G40.3 | Generalized idiopathic epilepsy and epileptic syndromes |
| G40.30 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable |
| G40.301 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus |
| G40.309 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.31 | Generalized idiopathic epilepsy and epileptic syndromes, intractable |
| G40.311 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus |
| G40.319 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.4 | Other generalized epilepsy and epileptic syndromes |
| G40.40 | Other generalized epilepsy and epileptic syndromes, not intractable |
| G40.401 | Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus |
| G40.409 | Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.41 | Other generalized epilepsy and epileptic syndromes, intractable |
| G40.411 | Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus |
| G40.419 | Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.5 | Epileptic seizures related to external causes |
| G40.50 | Epileptic seizures related to external causes, not intractable |
| G40.501 | Epileptic seizures related to external causes, not intractable, with status epilepticus |
| G40.509 | Epileptic seizures related to external causes, not intractable, without status epilepticus |
| G40.8 | Other epilepsy and recurrent seizures |
| G40.80 | Other epilepsy |
| G40.801 | Other epilepsy, not intractable, with status epilepticus |
| G40.802 | Other epilepsy, not intractable, without status epilepticus |
| G40.803 | Other epilepsy, intractable, with status epilepticus |
| G40.804 | Other epilepsy, intractable, without status epilepticus |
| G40.81 | Lennox-gastaut syndrome |
| G40.811 | Lennox-gastaut syndrome, not intractable, with status epilepticus |
| G40.812 | Lennox-gastaut syndrome, not intractable, without status epilepticus |
| G40.813 | Lennox-gastaut syndrome, intractable, with status epilepticus |
| G40.814 | Lennox-gastaut syndrome, intractable, without status epilepticus |
| G40.82 | Epileptic spasms |
| G40.821 | Epileptic spasms, not intractable, with status epilepticus |
| G40.822 | Epileptic spasms, not intractable, without status epilepticus |
| G40.823 | Epileptic spasms, intractable, with status epilepticus |
| G40.824 | Epileptic spasms, intractable, without status epilepticus |
| G40.89 | Other seizures |
| G40.9 | Epilepsy, unspecified |
| G40.90 | Epilepsy, unspecified, not intractable |
| G40.901 | Epilepsy, unspecified, not intractable, with status epilepticus |
| G40.909 | Epilepsy, unspecified, not intractable, without status epilepticus |
| G40.91 | Epilepsy, unspecified, intractable |
| G40.911 | Epilepsy, unspecified, intractable, with status epilepticus |
| G40.919 | Epilepsy, unspecified, intractable, without status epilepticus |
| G40.A | Absence epileptic syndrome |
| G40.A0 | Absence epileptic syndrome, not intractable |
| G40.A01 | Absence epileptic syndrome, not intractable, with status epilepticus |
| G40.A09 | Absence epileptic syndrome, not intractable, without status epilepticus |
| G40.A1 | Absence epileptic syndrome, intractable |
| G40.A11 | Absence epileptic syndrome, intractable, with status epilepticus |
| G40.A19 | Absence epileptic syndrome, intractable, without status epilepticus |
| G40.B | Juvenile myoclonic epilepsy [impulsive petit mal] |
| G40.B0 | Juvenile myoclonic epilepsy, not intractable |
| G40.B01 | Juvenile myoclonic epilepsy, not intractable, with status epilepticus |
| G40.B09 | Juvenile myoclonic epilepsy, not intractable, without status epilepticus |
| G40.B1 | Juvenile myoclonic epilepsy, intractable |
| G40.B11 | Juvenile myoclonic epilepsy, intractable, with status epilepticus |
| G40.B19 | Juvenile myoclonic epilepsy, intractable, without status epilepticus |
| 0-9 | A-Z |
|---|---|
| E88.42 | MERRF syndrome |
| G40 | Epilepsy and recurrent seizures |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.001 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.011 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.101 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.111 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.201 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.211 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| G40.3 | Generalized idiopathic epilepsy and epileptic syndromes |
| G40.30 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable |
| G40.301 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus |
| G40.309 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.31 | Generalized idiopathic epilepsy and epileptic syndromes, intractable |
| G40.311 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus |
| G40.319 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.4 | Other generalized epilepsy and epileptic syndromes |
| G40.40 | Other generalized epilepsy and epileptic syndromes, not intractable |
| G40.401 | Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus |
| G40.409 | Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40.41 | Other generalized epilepsy and epileptic syndromes, intractable |
| G40.411 | Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus |
| G40.419 | Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40.5 | Epileptic seizures related to external causes |
| G40.50 | Epileptic seizures related to external causes, not intractable |
| G40.501 | Epileptic seizures related to external causes, not intractable, with status epilepticus |
| G40.509 | Epileptic seizures related to external causes, not intractable, without status epilepticus |
| G40.8 | Other epilepsy and recurrent seizures |
| G40.80 | Other epilepsy |
| G40.801 | Other epilepsy, not intractable, with status epilepticus |
| G40.802 | Other epilepsy, not intractable, without status epilepticus |
| G40.803 | Other epilepsy, intractable, with status epilepticus |
| G40.804 | Other epilepsy, intractable, without status epilepticus |
| G40.81 | Lennox-gastaut syndrome |
| G40.811 | Lennox-gastaut syndrome, not intractable, with status epilepticus |
| G40.812 | Lennox-gastaut syndrome, not intractable, without status epilepticus |
| G40.813 | Lennox-gastaut syndrome, intractable, with status epilepticus |
| G40.814 | Lennox-gastaut syndrome, intractable, without status epilepticus |
| G40.82 | Epileptic spasms |
| G40.821 | Epileptic spasms, not intractable, with status epilepticus |
| G40.822 | Epileptic spasms, not intractable, without status epilepticus |
| G40.823 | Epileptic spasms, intractable, with status epilepticus |
| G40.824 | Epileptic spasms, intractable, without status epilepticus |
| G40.89 | Other seizures |
| G40.9 | Epilepsy, unspecified |
| G40.90 | Epilepsy, unspecified, not intractable |
| G40.901 | Epilepsy, unspecified, not intractable, with status epilepticus |
| G40.909 | Epilepsy, unspecified, not intractable, without status epilepticus |
| G40.91 | Epilepsy, unspecified, intractable |
| G40.911 | Epilepsy, unspecified, intractable, with status epilepticus |
| G40.919 | Epilepsy, unspecified, intractable, without status epilepticus |
| G40.A | Absence epileptic syndrome |
| G40.A | Absence epileptic syndrome |
| G40.A0 | Absence epileptic syndrome, not intractable |
| G40.A0 | Absence epileptic syndrome, not intractable |
| G40.A01 | Absence epileptic syndrome, not intractable, with status epilepticus |
| G40.A09 | Absence epileptic syndrome, not intractable, without status epilepticus |
| G40.A09 | Absence epileptic syndrome, not intractable, without status epilepticus |
| G40.A1 | Absence epileptic syndrome, intractable |
| G40.A1 | Absence epileptic syndrome, intractable |
| G40.A11 | Absence epileptic syndrome, intractable, with status epilepticus |
| G40.A19 | Absence epileptic syndrome, intractable, without status epilepticus |
| G40.A19 | Absence epileptic syndrome, intractable, without status epilepticus |
| G40.B | Juvenile myoclonic epilepsy [impulsive petit mal] |
| G40.B0 | Juvenile myoclonic epilepsy, not intractable |
| G40.B01 | Juvenile myoclonic epilepsy, not intractable, with status epilepticus |
| G40.B09 | Juvenile myoclonic epilepsy, not intractable, without status epilepticus |
| G40.B1 | Juvenile myoclonic epilepsy, intractable |
| G40.B11 | Juvenile myoclonic epilepsy, intractable, with status epilepticus |
| G40.B19 | Juvenile myoclonic epilepsy, intractable, without status epilepticus |
Formulary Reference Tool